Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Suppression of acute ethanol-induced hepatic steatosis by docosahexaenoic acid is associated with downregulation of stearoyl-CoA desaturase 1 and inflammatory cytokines.

Huang LL, Wan JB, Wang B, He CW, Ma H, Li TW, Kang JX.

Prostaglandins Leukot Essent Fatty Acids. 2013 May;88(5):347-53. doi: 10.1016/j.plefa.2013.02.002. Epub 2013 Mar 7.

PMID:
23474173
2.

Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice.

Liu G, Zhang Y, Liu C, Xu D, Zhang R, Cheng Y, Pan Y, Huang C, Chen Y.

J Nutr. 2014 Jul;144(7):1009-15. doi: 10.3945/jn.114.193128. Epub 2014 May 14.

3.

Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.

Trebicka J, Racz I, Siegmund SV, Cara E, Granzow M, Schierwagen R, Klein S, Wojtalla A, Hennenberg M, Huss S, Fischer HP, Heller J, Zimmer A, Sauerbruch T.

Liver Int. 2011 Jul;31(6):860-70. doi: 10.1111/j.1478-3231.2011.02496.x. Epub 2011 Mar 8.

PMID:
21645218
4.

Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice.

Kajikawa S, Harada T, Kawashima A, Imada K, Mizuguchi K.

Prostaglandins Leukot Essent Fatty Acids. 2009 Apr;80(4):229-38. doi: 10.1016/j.plefa.2009.02.004. Epub 2009 Mar 27.

PMID:
19328666
5.

Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet.

Yang ZH, Miyahara H, Takeo J, Hatanaka A, Katayama M.

Lipids Health Dis. 2011 Oct 25;10:189. doi: 10.1186/1476-511X-10-189.

6.

A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis.

Kurikawa N, Takagi T, Wakimoto S, Uto Y, Terashima H, Kono K, Ogata T, Ohsumi J.

Biol Pharm Bull. 2013;36(2):259-67.

7.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
8.

N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury.

Zúñiga J, Cancino M, Medina F, Varela P, Vargas R, Tapia G, Videla LA, Fernández V.

PLoS One. 2011;6(12):e28502. doi: 10.1371/journal.pone.0028502. Epub 2011 Dec 8.

9.

Endogenously elevated n-3 polyunsaturated fatty acids alleviate acute ethanol-induced liver steatosis.

Huang W, Wang B, Li X, Kang JX.

Biofactors. 2015 Nov-Dec;41(6):453-62. doi: 10.1002/biof.1246. Epub 2015 Dec 6.

PMID:
26637972
10.

Quantitative lipid metabolomic changes in alcoholic micropigs with fatty liver disease.

Zivkovic AM, Bruce German J, Esfandiari F, Halsted CH.

Alcohol Clin Exp Res. 2009 Apr;33(4):751-8. doi: 10.1111/j.1530-0277.2008.00892.x. Epub 2009 Jan 21.

11.

Down-regulation of hepatic stearoyl-CoA desaturase 1 expression by angiotensin II receptor blocker in the obese fa/fa Zucker rat: possible role in amelioration of insulin resistance and hepatic steatosis.

Yokozawa J, Sasaki T, Ohwada K, Sasaki Y, Ito JI, Saito T, Kawata S.

J Gastroenterol. 2009;44(6):583-91. doi: 10.1007/s00535-009-0042-x. Epub 2009 Apr 14.

PMID:
19365601
12.

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in mice.

Kong L, Ren W, Li W, Zhao S, Mi H, Wang R, Zhang Y, Wu W, Nan Y, Yu J.

Lipids Health Dis. 2011 Dec 30;10:246. doi: 10.1186/1476-511X-10-246.

13.
14.

Recent advances on stearoyl-Coa desaturase regulation in fatty liver diseases.

Narce M, Bellenger J, Rialland M, Bellenger S.

Curr Drug Metab. 2012 Dec;13(10):1454-63. Review.

PMID:
22978399
15.

Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha.

Miyazaki M, Dobrzyn A, Sampath H, Lee SH, Man WC, Chu K, Peters JM, Gonzalez FJ, Ntambi JM.

J Biol Chem. 2004 Aug 13;279(33):35017-24. Epub 2004 Jun 4.

16.

Diet rich in Docosahexaenoic Acid/Eicosapentaenoic Acid robustly ameliorates hepatic steatosis and insulin resistance in seipin deficient lipodystrophy mice.

Xu P, Wang H, Kayoumu A, Wang M, Huang W, Liu G.

Nutr Metab (Lond). 2015 Dec 18;12:58. doi: 10.1186/s12986-015-0054-x. eCollection 2015.

17.

Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids.

Song BJ, Moon KH, Olsson NU, Salem N Jr.

J Hepatol. 2008 Aug;49(2):262-73. doi: 10.1016/j.jhep.2008.04.023. Epub 2008 Jun 4.

18.

Deletion of circadian gene Per1 alleviates acute ethanol-induced hepatotoxicity in mice.

Wang T, Yang P, Zhan Y, Xia L, Hua Z, Zhang J.

Toxicology. 2013 Dec 15;314(2-3):193-201. doi: 10.1016/j.tox.2013.09.009. Epub 2013 Oct 18.

PMID:
24144995
19.

Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.

Shen Z, Liang X, Rogers CQ, Rideout D, You M.

Am J Physiol Gastrointest Liver Physiol. 2010 Mar;298(3):G364-74. doi: 10.1152/ajpgi.00456.2009. Epub 2009 Dec 10.

20.

Silymarin protects against acute ethanol-induced hepatotoxicity in mice.

Song Z, Deaciuc I, Song M, Lee DY, Liu Y, Ji X, McClain C.

Alcohol Clin Exp Res. 2006 Mar;30(3):407-13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk